Opaleye Management’s OptiNose OPTN Stock Holding History

Opaleye Management’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-193,039	Closed	-$1.77M	–	46
2025 Q1	$1.77M	Buy	+193,039	New	+$1.21M	0.39%	35
2022 Q4	–	Sell	-6,065	Closed	-$333K	–	47
2022 Q3	$333K	Hold	6,065	–	–	0.14%	39
2022 Q2	$333K	Buy	+6,065	New	+$223K	0.15%	42
2021 Q4	–	Sell	-103,900	Closed	-$4.68M	–	44
2021 Q3	$4.68M	Buy	103,900 +22,127	+27%	+$928K	0.87%	30
2021 Q2	$3.81M	Buy	81,773 +26,706	+48%	+$1.36M	0.63%	37
2021 Q1	$3.05M	Buy	55,067 +26,067	+90%	+$1.59M	0.45%	45
2020 Q4	$1.8M	Buy	+29,000	New	+$1.78M	0.24%	50

Opaleye Management's OPTN Position: Q2 2025 in Review

Opaleye Management sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 193,039 shares — an estimated $1.77M sold.

Opaleye Management first reported a position in OPTN in Q4 2020 and held it in 7 quarters. The position peaked at $4.68M in Q3 2021. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.

Opaleye Management reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
Opaleye Management sold 193,039 OptiNose shares in Q2 2025, an estimated $1.77M.
Opaleye Management first reported a position in OptiNose in Q4 2020 and held it in 7 quarters.
Opaleye Management's OptiNose position peaked at $4.68M in Q3 2021.
0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.

Based on Opaleye Management's 13F filing for Q2 2025, filed 14 Aug 2025.